Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Doctors To HHS: Exclude Textbooks And Reprints From Sunshine Act, Or Else
Pharmalot
Tuesday, October 29, 2013 - 12:07pm
tags:
Physician Payment Sunshine Act, physicians, HHS
Actavis Q3 Merely In Line, But Stock Hits High
Investors.com
Tuesday, October 29, 2013 - 12:06pm
tags:
Actavis, earnings
Is Pessimism Warranted for These 3 Most Hated Biotech Stocks?
Motley Fool
Tuesday, October 29, 2013 - 12:03pm
tags:
Dendreon, Sarepta Therapeutics, Spectrum Pharmaceuticals
United Therapeutics profit misses estimates as expenses rise
Yahoo/Reuters
Tuesday, October 29, 2013 - 10:46am
tags:
earnings, United Therapeutics
Glaxo Seeks EU Approval for HIV Drug
Yahoo/Zacks
Tuesday, October 29, 2013 - 10:44am
tags:
GSK, Europe, HIV, Tivicay, ViiV Healthcare, abacavir, lamivudine
Allergan Agrees to Sell Obesity Unit; 3rd-Quarter Profit Up 20%
NASDAQ.com
Tuesday, October 29, 2013 - 10:02am
tags:
Allergan, obesity, earnings, M&A, Apollo Endosurgery
With The FDA Reviewing Bunavail, BioDelivery Might Be A Buy
Seeking Alpha
Tuesday, October 29, 2013 - 9:58am
tags:
Bunavail, BioDelivery Sciences, Actavis, Titan Pharmaceuticals, Reckitt Benckiser
Celgene unit announces apremilast phase III study results
The Fly on the Wall
Tuesday, October 29, 2013 - 9:46am
tags:
Celgene, apremilast, psoriatic arthritis, Celgene International Sarl
New Technology Puts Actinium On The Radar
Seeking Alpha
Tuesday, October 29, 2013 - 9:44am
tags:
Actinium Pharmaceuticals, hematologic cancers, alpha radiation
Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tuesday, October 29, 2013 - 9:42am
tags:
Clovis Oncology, Synta, Incyte, CO-1686, non-small cell lung cancer, ganetespib, INCB39110, rheumatoid arthritis
Enzo Biochem, Sequenom partner to market prenatal testing service
Yahoo/Fly on the Wall
Tuesday, October 29, 2013 - 9:35am
tags:
Enzo Biochem, Sequenom, prenatal testing, Maternit21 Plus
The Value Of Sanofi Lies In Its Predictability
Seeking Alpha
Tuesday, October 29, 2013 - 9:32am
tags:
Sanofi
Pfizer 3Q net falls due to generics, higher costs
Yahoo/AP
Tuesday, October 29, 2013 - 9:30am
tags:
Pfizer, earnings
Recent FDA News Makes A Zalicus Trade Look Even More Compelling
Seeking Alpha
Tuesday, October 29, 2013 - 9:24am
tags:
FDA, Zalicus, Z160, Zohydro ER, Zogenix, painkillers
Why Gilead's Sofosbuvir Is Better Than J&J's Simeprevir
Motley Fool
Tuesday, October 29, 2013 - 9:21am
tags:
Gilead, sofosbuvir, JNJ, hepatitis C, simeprevir
Vertex to reduce workforce, focus on opportunities in Cystic Fibrosis, other R&D
The Fly on the Wall
Tuesday, October 29, 2013 - 9:18am
tags:
Vertex Pharmaceuticals, layoffs, cystic fibrosis
4 Healthcare Stock Stories Getting Noticed on Monday
Wall St. Cheat Sheet
Monday, October 28, 2013 - 7:46pm
tags:
Merck, Teva, Clovis Oncology, Illumina
Eli Lilly: Cymbalta Patent Expiry Quantified
Seeking Alpha
Monday, October 28, 2013 - 3:33pm
tags:
patents, Eli Lilly, Cymbalta, Pfizer, Merck, antidepressants
3 Takeaways You Need to Know From Merck's Earnings
Motley Fool
Monday, October 28, 2013 - 3:29pm
tags:
Merck, earnings, Januvia, Singulair, Gardasil
Earnings Preview: Pfizer's new drug sales will be critical in Q3 report
The Fly on the Wall
Monday, October 28, 2013 - 3:19pm
tags:
earnings, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.